Search





Search





Markets
/
Stocks
/
tmci
/

Treace Medical Concepts Inc

TMCI

Add to Watchlist

4.310USD

-0.070-1.60%

Close 07-31 16:00（ET）Quotes delayed by 15 min

279.60MMarket Cap

LossP/E TTM

Treace Medical Concepts Inc

4.310

-0.070-1.60%

Financial Summary Income Statement Balance Sheet Cash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial Summary Income Statement Balance Sheet Cash Flow Statement

TMCI Cash Flow Statement

You can access the annual and quarterly cash flow statements of Treace Medical Concepts Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q1

Operating cash flows (indirect method)

Cash flow from continuing operating activities

72.46%7.24M

-90.78%-8.03M

23.22%-9.09M

78.05%-3.05M

158.14%4.20M

-890.79%-4.21M

-24.48%-11.84M

-66.73%-13.90M

58.16%-7.22M

109.93%532.00K

-27.13%-9.51M

21.11%-8.34M

-138.35%-17.26M

-42.80%-5.36M

19.22%-7.48M

-183.19%-10.57M

-1523.54%-7.24M

---3.75M

---9.26M

---3.73M

50.17%-446.00K

---895.00K

Net income from continuing operations

-12.81%-17.96M

-1775.05%-9.39M

-6.04%-16.29M

17.96%-17.40M

14.75%-15.92M

92.02%-501.00K

12.33%-15.36M

-72.81%-21.21M

-38.81%-18.68M

-42.36%-6.28M

-44.41%-17.52M

28.80%-12.27M

-48.89%-13.45M

33.34%-4.41M

-89.05%-12.13M

-239.05%-17.23M

-271.55%-9.04M

---6.62M

---6.42M

---5.08M

-51.34%-2.43M

---1.61M

Operating gains losses

-63.47%899.00K

25.53%2.81M

28.79%2.78M

21.74%2.58M

28.92%2.46M

26.46%2.24M

37.92%2.16M

93.24%2.12M

106.60%1.91M

40.06%1.77M

240.74%1.56M

158.87%1.09M

176.65%924.00K

357.61%1.26M

142.86%459.00K

310.68%423.00K

185.47%334.00K

--276.00K

--189.00K

--103.00K

-61.51%117.00K

--304.00K

Other non-cash items

21.79%1.54M

63.68%4.12M

301.86%1.09M

-70.80%705.00K

111.04%1.26M

265.41%2.51M

-214.44%-539.00K

852.02%2.41M

-48.14%598.00K

-38.35%688.00K

-50.00%471.00K

-106.30%-321.00K

182.60%1.15M

171.53%1.12M

519.74%942.00K

2986.67%5.09M

768.85%408.00K

--411.00K

--152.00K

--165.00K

-131.94%-61.00K

--191.00K

Change in working capital

91.21%14.73M

22.94%-13.11M

22.20%-4.67M

137.62%1.49M

400.26%7.70M

-1022.16%-17.01M

-868.25%-6.00M

-812.67%-3.96M

117.96%1.54M

73.84%-1.52M

-20.31%781.00K

40.38%-434.00K

-3123.31%-8.57M

-753.33%-5.79M

124.79%980.00K

-448.33%-728.00K

-117.41%-266.00K

--887.00K

---3.95M

--209.00K

19000.00%1.53M

--8.00K

-Change in receivables

25.79%11.69M

44.64%-9.52M

-311.67%-2.56M

-71.89%696.00K

18.77%9.29M

-28.09%-17.19M

-45.95%1.21M

229.84%2.48M

106.20%7.82M

-20.95%-13.42M

208.81%2.23M

-343.49%-1.91M

49.21%3.79M

-59.14%-11.10M

-16.44%-2.05M

-157.95%-430.00K

-32.56%2.54M

---6.97M

---1.76M

--742.00K

-1.00%3.77M

--3.81M

-Change in inventory

-125.48%-335.00K

23.81%5.39M

141.72%973.00K

17.75%-4.46M

119.88%1.31M

6401.49%4.36M

27.37%-2.33M

-54.17%-5.42M

-107.43%-6.62M

102.44%67.00K

11.22%-3.21M

-88.78%-3.52M

-481.93%-3.19M

-625.40%-2.74M

-29.22%-3.62M

-378.66%-1.86M

-214.64%-548.00K

---378.00K

---2.80M

---389.00K

135.15%478.00K

---1.36M

-Change in prepaid expenses

-55.59%608.00K

-48.29%697.00K

-194.18%-615.00K

-176.49%-1.28M

191.57%1.37M

840.66%1.35M

6.53%653.00K

347.79%1.68M

-55.24%-1.50M

-146.67%-182.00K

3326.32%613.00K

70.16%-678.00K

-178.10%-963.00K

-48.07%390.00K

92.37%-19.00K

10.55%-2.27M

425.33%1.23M

--751.00K

---249.00K

---2.54M

-357.82%-379.00K

--147.00K

-Change in other current assets

-285.53%-293.00K

-1011.11%-200.00K

119.87%62.00K

---289.00K

---76.00K

---18.00K

---312.00K

----

100.00%0.00

--0.00

100.00%0.00

--69.00K

48.51%-69.00K

--0.00

---12.00K

--0.00

---134.00K

----

-Change in other current liabilities

312.28%235.00K

-159.79%-58.00K

128.35%36.00K

-100.00%0.00

-36.67%57.00K

--97.00K

-6450.00%-127.00K

-2.63%37.00K

--90.00K

--0.00

--2.00K

--38.00K

----

Cash from non-recurring investing activities

Cash from operating activities

72.46%7.24M

-90.78%-8.03M

23.22%-9.09M

78.05%-3.05M

158.14%4.20M

-890.79%-4.21M

-24.48%-11.84M

-66.73%-13.90M

58.16%-7.22M

109.93%532.00K

-27.13%-9.51M

21.11%-8.34M

-138.35%-17.26M

-42.80%-5.36M

19.22%-7.48M

-183.19%-10.57M

-1523.54%-7.24M

---3.75M

---9.26M

---3.73M

50.17%-446.00K

---895.00K

Investing cash flow

Net cash from continuing investing activities

-13.58%3.06M

-21.99%2.40M

-1.89%2.81M

175.71%4.77M

-9.78%3.54M

36.74%3.07M

-18.22%2.86M

-59.13%1.73M

165.70%3.93M

-3.60%2.25M

-40.23%3.50M

-18.13%4.23M

-0.20%1.48M

159.11%2.33M

523.75%5.86M

671.34%5.17M

655.61%1.48M

--900.00K

--939.00K

--670.00K

-70.92%196.00K

--674.00K

Capital expenditures

-13.58%3.06M

-21.99%2.40M

-1.89%2.81M

175.71%4.77M

-9.78%3.54M

36.74%3.07M

-18.22%2.86M

-59.13%1.73M

165.70%3.93M

-3.60%2.25M

-40.23%3.50M

-18.13%4.23M

-0.20%1.48M

159.11%2.33M

523.75%5.86M

671.34%5.17M

655.61%1.48M

--900.00K

--939.00K

--670.00K

-70.92%196.00K

--674.00K

Net cash flow from disposal of fixed assets

-13.58%3.06M

-21.99%2.40M

-1.89%2.81M

175.71%4.77M

-9.78%3.54M

36.74%3.07M

-18.22%2.86M

-59.13%1.73M

165.70%3.93M

-3.60%2.25M

-40.23%3.50M

-18.13%4.23M

-0.20%1.48M

159.11%2.33M

523.75%5.86M

671.34%5.17M

655.61%1.48M

--900.00K

--939.00K

--670.00K

-70.92%196.00K

--674.00K

Net cash flow from business transactions

----

--0.00

----

--0.00

---20.00M

----

Net cash flow from investment products

-388.30%-4.75M

85.74%12.06M

33.84%11.54M

-93.75%1.51M

-78.54%1.65M

-10.48%6.50M

6.52%8.63M

74.99%24.16M

109.73%7.69M

111.76%7.25M

--8.10M

--13.81M

---79.00M

---61.68M

----

Net cash flow from other investing activities

--0.00

----

Cash from non-current investing activities

Net cash flow from investing activities

-312.67%-7.82M

182.55%9.67M

51.59%8.74M

-114.52%-3.26M

-150.40%-1.89M

-31.68%3.42M

25.36%5.76M

315.23%22.43M

104.67%3.76M

107.82%5.01M

178.49%4.60M

-101.68%-10.42M

-5334.17%-80.48M

-7012.44%-64.01M

-523.75%-5.86M

-671.34%-5.17M

-655.61%-1.48M

---900.00K

---939.00K

---670.00K

70.92%-196.00K

---674.00K

Financing cash flow

Cash flow from continuous financing activities

-108.51%-588.00K

5215.38%1.38M

-225.00%-10.00K

217.36%987.00K

-52.43%-282.00K

-84.24%26.00K

-94.97%8.00K

-73.64%311.00K

-100.17%-185.00K

-44.44%165.00K

-54.96%159.00K

-93.72%1.18M

7762.90%107.88M

-71.05%297.00K

760.98%353.00K

-82.58%18.78M

212.55%1.37M

--1.03M

--41.00K

--107.80M

-3793.94%-1.22M

--33.00K

Net cash flow from debt Issuance/repayment

----

--3.00M

----

--0.00

----

--0.00

-100.00%0.00

----

--0.00

--19.61M

100.00%0.00

--0.00

---1.79M

--0.00

Net cash flow from common stock issuance/repurchase

----

--0.00

-100.00%0.00

--0.00

--107.53M

--0.00

----

--0.00

--107.61M

----

Proceeds from stock option exercised by employees

-23.53%91.00K

22.81%70.00K

2912.50%241.00K

-62.70%116.00K

128.85%119.00K

-67.98%57.00K

-94.97%8.00K

-73.64%311.00K

-85.23%52.00K

-40.07%178.00K

-54.96%159.00K

615.15%1.18M

-74.34%352.00K

-71.05%297.00K

760.98%353.00K

-14.95%165.00K

141.12%1.37M

--1.03M

--41.00K

--194.00K

1287.80%569.00K

--41.00K

Net cash flow from other financing activities

-69.33%-679.00K

-5329.03%-1.68M

---251.00K

--871.00K

-69.20%-401.00K

-138.46%-31.00K

--0.00

---237.00K

---13.00K

--0.00

100.00%0.00

----

--0.00

---989.00K

----

--0.00

----

100.00%0.00

---8.00K

Net cash from non-recurrent financing activities

Net cash from financing activities

-108.51%-588.00K

5215.38%1.38M

-225.00%-10.00K

217.36%987.00K

-52.43%-282.00K

-84.24%26.00K

-94.97%8.00K

-73.64%311.00K

-100.17%-185.00K

-44.44%165.00K

-54.96%159.00K

-93.72%1.18M

7762.90%107.88M

-71.05%297.00K

760.98%353.00K

-82.58%18.78M

212.55%1.37M

--1.03M

--41.00K

--107.80M

-3793.94%-1.22M

--33.00K

Net cash flow

Beginning cash balance

-5.66%10.71M

-36.53%7.69M

-55.71%8.05M

43.26%13.37M

-12.57%11.35M

66.39%12.11M

51.07%18.18M

-68.48%9.33M

-33.33%12.98M

-91.78%7.28M

-88.15%12.04M

-69.93%29.61M

-81.60%19.47M

-19.11%88.55M

-15.12%101.53M

507.25%98.48M

485.39%105.83M

--109.46M

--119.62M

--16.22M

48.93%18.08M

--12.14M

Current period cash flow changes

-157.57%-1.16M

497.63%3.02M

93.97%-366.00K

-160.13%-5.32M

155.43%2.02M

-113.32%-760.00K

-27.62%-6.07M

150.33%8.85M

-135.98%-3.65M

108.26%5.70M

63.37%-4.76M

-676.33%-17.58M

237.96%10.14M

-1804.94%-69.07M

-27.80%-12.99M

-97.05%3.05M

-294.95%-7.35M

---3.63M

---10.16M

--103.40M

-21.16%-1.86M

---1.54M

Ending cash balance

-28.63%9.54M

-5.66%10.71M

-36.53%7.69M

-55.71%8.05M

43.26%13.37M

-12.57%11.35M

66.39%12.11M

51.07%18.18M

-68.48%9.33M

-33.33%12.98M

-91.78%7.28M

-88.15%12.04M

-69.93%29.61M

-81.60%19.47M

-19.11%88.55M

-15.12%101.53M

507.25%98.48M

--105.83M

--109.46M

--119.62M

52.96%16.22M

--10.60M

Free cash flow

537.86%4.18M

-43.17%-10.42M

19.07%-11.90M

49.97%-7.82M

105.88%655.00K

-324.30%-7.28M

-12.99%-14.71M

-24.35%-15.63M

40.50%-11.15M

77.69%-1.72M

2.44%-13.01M

20.13%-12.57M

-114.82%-18.74M

-65.31%-7.69M

-30.75%-13.34M

-257.51%-15.73M

-1258.57%-8.72M

---4.65M

---10.20M

---4.40M

59.08%-642.00K

---1.57M

Currency unit

--USD

Audit opinions

----

FAQs

What is operating cash flow?



Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did Treace Medical Concepts Inc Generate?



Treace Medical Concepts Inc generated -15.97M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did Treace Medical Concepts Inc's Operating Cash Flow Change Year Over Year?



Treace Medical Concepts Inc's operating cash flow increased by 57.03% year over year.

What is investing cash flow?



Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

How Much Does Treace Medical Concepts Inc Spend on Capital Expenditures?



Treace Medical Concepts Inc spent 13.52M on capital expenditures in the most recent quarter。

What is financing cash flow?



Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has Treace Medical Concepts Inc's Financing Cash Flow Changed?



Treace Medical Concepts Inc used 2.08M in financing activities in the latest quarter.

What is free cash flow and why does it matter for TMCI?



Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.

What was Treace Medical Concepts Inc’s free cash flow in the latest quarter?



Free cash flow was -29.49M reflecting a 39.53% change from the previous year.